Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Royalty Pharma plc | 73,947 | reported | 31 Mar 2026 | tx 30+73,947 |
| Kaleido Biosciences, Inc. | 15,000 | reported | 30 Jun 2021 | tx 2+30,000 |
| REGENERON PHARMACEUTICALS, INC. | 1,703 | reported | 07 Jan 2026 | tx 95+78,612−59,516 |
| Cidara Therapeutics, Inc. | 0 | reported | 07 Jan 2026 | tx 15+152,225−35,390 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 31 Mar 2026 | GRANT_AWARD | Royalty Pharma plc | 815 | 45.98 USD | |
| 07 Jan 2026 | SALE | REGENERON PHARMACEUTICALS, INC. | 1,500 | 800.00 USD | |
| 07 Jan 2026 | EXERCISE | REGENERON PHARMACEUTICALS, INC. | 1,500 | 374.12 USD | |
| 07 Jan 2026 | EXERCISE | REGENERON PHARMACEUTICALS, INC. | 1,500 | 0.00 USD | deriv |
| 07 Jan 2026 | OTHER | Cidara Therapeutics, Inc. | 15 | 221.50 USD | |
| 07 Jan 2026 | OTHER | Cidara Therapeutics, Inc. | 1,750 | — | deriv |
| 07 Jan 2026 | OTHER | Cidara Therapeutics, Inc. | 875 | — | deriv |
| 07 Jan 2026 | OTHER | Cidara Therapeutics, Inc. | 11,100 | — | deriv |
| 07 Jan 2026 | OTHER | Cidara Therapeutics, Inc. | 16,000 | — | deriv |
| 07 Jan 2026 | OTHER | Cidara Therapeutics, Inc. | 2,125 | — | deriv |
| 07 Jan 2026 | OTHER | Cidara Therapeutics, Inc. | 2,125 | — | deriv |
| 07 Jan 2026 | OTHER | Cidara Therapeutics, Inc. | 1,400 | — | deriv |
| 02 Jan 2026 | GRANT_AWARD | REGENERON PHARMACEUTICALS, INC. | 155 | 0.00 USD | |
| 02 Jan 2026 | GRANT_AWARD | REGENERON PHARMACEUTICALS, INC. | 1,962 | 0.00 USD | deriv |
| 31 Dec 2025 | GRANT_AWARD | Royalty Pharma plc | 967 | 38.74 USD | |
| 20 Nov 2025 | SALE | REGENERON PHARMACEUTICALS, INC. | 760 | 750.00 USD | |
| 20 Nov 2025 | EXERCISE | REGENERON PHARMACEUTICALS, INC. | 760 | 371.40 USD | |
| 20 Nov 2025 | EXERCISE | REGENERON PHARMACEUTICALS, INC. | 760 | 0.00 USD | deriv |
| 30 Sept 2025 | GRANT_AWARD | Royalty Pharma plc | 1,047 | 35.79 USD | |
| 30 Jun 2025 | GRANT_AWARD | Royalty Pharma plc | 1,064 | 35.24 USD | |
| 18 Jun 2025 | GRANT_AWARD | Cidara Therapeutics, Inc. | 11,100 | 0.00 USD | deriv |
| 13 May 2025 | GRANT_AWARD | Royalty Pharma plc | 7,614 | 0.00 USD | |
| 31 Mar 2025 | GRANT_AWARD | Royalty Pharma plc | 1,141 | 32.87 USD | |
| 02 Jan 2025 | GRANT_AWARD | REGENERON PHARMACEUTICALS, INC. | 166 | 0.00 USD | |
| 02 Jan 2025 | GRANT_AWARD | REGENERON PHARMACEUTICALS, INC. | 1,958 | 0.00 USD | deriv |